Neuberger and KKR to Invest in Datavant Alongside New Mountain Capital

NEW YORK, New York – September 15, 2026 – Datavant, the data collaboration platform trusted for healthcare, New Mountain Capital, Neuberger, and KKR today announced that Neuberger Capital Solutions, along with funds managed by Neuberger Private Markets (collectively, “Neuberger”), and investment funds and accounts managed by KKR have agreed to acquire a significant minority stake in Datavant (the “Company”). New Mountain Capital (“New Mountain”), which has been an investor in Datavant since 2014, will retain its control position in the Company.                  

Datavant is the nation’s largest health data ecosystem, enabling patients, providers, payers, health data analytics companies, patient-facing applications, government agencies, and life science companies to securely exchange and organize their patient-level data for use cases ranging from clinical care and value-based payments to health analytics and medical research. Today, the Company’s ecosystem reaches 80,000+ providers, 75 of the top 100 health systems, and 350+ ecosystem partners, with Datavant's healthcare data touching 90% of the U.S. population and 80% of Medicare Advantage plan participants. 

Neuberger and KKR will support Datavant's strategic vision and growth alongside New Mountain and existing shareholders. The strategic partnership reflects a shared commitment to Datavant's mission to make the world’s health data secure, accessible and actionable.  

“From our work on both the supply and demand side of health data, we see the pressure points and opportunities to make it easier to move, protect, and use health data across a complex and evolving environment,” said Kyle Armbrester, CEO of Datavant. "We were deliberate in choosing the best strategic partners for our business, who align with our mission and believe strongly in our long-term vision. With New Mountain, Neuberger, and KKR by our side, we're well equipped to deepen our impact across the healthcare ecosystem and accelerate into our next phase of growth."

"Since our initial investment in 2014, Datavant has become the connective tissue for health data across the industry and is poised to lead the next era of connected data and clinical AI. We are excited to welcome Neuberger and KKR as strategic partners as we accelerate this next phase of growth,” said Brian Murphy and Gandhi Bedi, Managing Directors at New Mountain.     

"Datavant is deeply embedded across providers, payers, and life sciences, with a scaled data network that's difficult to replicate. Kyle and his team have earned the trust of the healthcare ecosystem through years of disciplined execution, turning that position into real efficiency and compliance gains for customers. We look forward to working with the Datavant team, New Mountain, and KKR to help write its next chapter," said David Lyon, Head of Neuberger Capital Solutions, and Nikhil Krishnan, Managing Director.       

“We have tremendous conviction in Datavant’s differentiated model, strong market position, and the mission critical role that it plays within the healthcare industry,” said Blaine MacDougald, partner, co-head of KKR’s Strategic Investments Group and James Paquette, managing director. “We believe it has the potential to scale even further, and we look forward to supporting the team with partnership capital that helps Datavant continue digitizing its platform and capturing attractive growth opportunities ahead.” 

KKR is investing in Datavant primarily through funds and accounts managed by its Strategic Investments Group. The transaction is expected to close in the fourth quarter of 2026 and is subject to customary closing conditions.

J.P. Morgan Securities LLC served as sole placement agent and lead financial advisor to Datavant, with Jefferies LLC and Wells Fargo also serving as financial advisors. Ropes & Gray served as legal advisor to Datavant and New Mountain. Latham & Watkins LLP served as legal advisor to Neuberger and KKR.

===============================================================================

Please refer to http://www.kkr.com/email-disclaimer for important disclosures regarding this electronic communication.
KKR uses your personal information in accordance with its privacy notices, which can be found on http://www.kkr.com.
===============================================================================